0001209191-17-012759.txt : 20170221 0001209191-17-012759.hdr.sgml : 20170220 20170221165041 ACCESSION NUMBER: 0001209191-17-012759 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170216 FILED AS OF DATE: 20170221 DATE AS OF CHANGE: 20170221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARCA biopharma, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 720-940-2200 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ozeroff Christopher David CENTRAL INDEX KEY: 0001454996 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22873 FILM NUMBER: 17625711 MAIL ADDRESS: STREET 1: 8001 ARISTA PLACE STREET 2: SUITE 200 CITY: BROOMFIELD STATE: CO ZIP: 80021 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-16 0 0000907654 ARCA biopharma, Inc. ABIO 0001454996 Ozeroff Christopher David 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 0 1 0 0 S.V.P., General Counsel Common Stock 18400 D Stock Option (right to buy) 2.50 2017-02-16 4 A 0 24000 0.00 A 2027-02-15 Common Stock 24000 24000 D Includes (i) remaining 2,443 previously reported shares issued as Restricted Stock Units ("RSUs") under the 2013 Amended and Restated Equity Incentive Plan (the "Plan") that vest in two equal annual installments beginning on 2/27/17, and (ii) 2,290 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning 4/2/17, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 13,667 previously reported shares of common stock held directly. Grant to the Reporting Person of a stock option under the Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested. /s/ Brian L. Selby, Attorney-in-Fact 2017-02-21